The development of biotechnological innovations is quickly becoming a globalized phenomenon as emerging nations are making major strides to compete with more developed economies. Though efforts to bridge the gap between emerging and developed nations have been successful, there are still many barriers that need to be overcome. Comparative Approaches to Biotechnology Development and Use in Developed and Emerging Nations evaluates the importance of manufacturing biotechnological products around the world. Highlighting a comparative analysis of public policies, technological policies, innovations, and marketing capabilities of developed and emerging nations, this publication is a pivotal reference source for government officers, policy makers, academics, and practitioners.

Clusters are geographic concentrations of interconnected companies, specialized suppliers, service providers, and associated institutions in a particular field that are present in a nation or region. The development and upgrading of clusters is an important agenda for governments, companies, and other institutions. Cluster growth initiatives are an important new direction in economic policy, building on earlier efforts in macroeconomic stabilization, privatization, market opening, and cost reduction related to doing business. Comparing High Technology Firms in Developed and Developing Countries: Cluster Growth Initiatives is the leading source of information for readers interested in this field of study as it promotes scientific discussion on policies and practice of cluster growth, as well as covers the emerging research topics which are going to define the future of the management of technology. Furthermore, this book demonstrates the effectiveness and efficiency of technology policy based on observations of differential growth rate of high technology firms in clusters, and explores the factors that explain superior performance of high technology firms to contribute the improvement of technology policy in both developed and developing countries.

Written by GABRIEL B¡ and F¡BIO MOON Art by F¡BIO MOON and GABRIEL B¡ Cover by GABRIEL B¡ “One of the most memorable things we’ve read in a long time.” — io9 “Beautifully written and utterly gorgeous, DAYTRIPPER completely blew me away.” — Gerard Way (Umbrella Academy, My Chemical Romance) What are the most important days of your life? F·bio Moon and Gabriel B· answer that question in the critical and commercial hit series that took the industry by storm, winning praise from such comics veterans as Terry Moore, Craig Thompson and Jeff Smith. Follow aspiring writer Br·s de Oliva Domingos as each chapter of DAYTRIPPER peers in at a completely different moment in his life. Moon and B· tell a beautifully lyrical tale chronicling Domingos’s entire existence – from his loves to his deaths and all the possibilities in between. Introduction by Craig Thompson (Blankets). On sale FEBRUARY 2 • 256 pg, FC, MATURE READERS

How to Talk to Girls at Parties by Sunday Times bestselling writer Neil Gaiman is a graphic novel with extraordinary artwork by the Eisner Award-winning duo Fabio Moon and Gabriel Ba. Soon to be a feature film starring Nicole Kidman, this adaptation is 'a quirky delight' (Audrey Niffenegger) and will appeal to fans of Alan Moore, Dave McKean and beyond. ENN is a fifteen-year-old boy who just doesn't understand girls, while his friend Vic seems to have them all figured out. Both teenagers are in for the shock of their young lives, however, when they crash a local party only to discover that the girls there are far, far more than they appear! From the Locus Award-winning short story by Neil Gaiman, one of the most celebrated authors of our time, and adapted in vibrant ink-and-watercolour illustrations by the Daytripper duo of brothers Fabio Moon and Gabriel Ba, this original graphic novel is not to be missed!

Ce livre essaie d'elucider pourquoi il y a des entreprises de biotechnologie qui croissent beaucoup plus rapidement que d'autres dans des conditions semblables, alors que la plupart restent stables pendant des longues periodes, ou simplement echouent. Nous voulons connaitre quels sont les facteurs expliquant cette croissance differentielle chez les firmes specialisees en biotechnologie. Pour y arriver, nous avons choisi de travailler avec les deux pays les plus importants au monde quant au nombre de firmes de biotechnologie: les Etats-Unis et le Royaume-Uni. Ces deux pays concentrent presque la moitie de la biotechnologie mondiale.